胸腺恶性肿瘤Masaoka-Koga分期相关术语的说明与定义
被引量:5
The Masaoka-Koga Stage Classificationfor Thymic MalignanciesClarification and Definition of Terms
摘要
目前,胸腺恶性肿瘤尚无国际抗癌联盟(International Union Against Cancer, UICC)和美国癌症联合委员会(American Joint Committeeon Cancer, AJCC)的官方分期。在2017年新版国际肿瘤分期提出较为广泛接受的分期之前,国际胸腺肿瘤协作组织(International Thymic Malignancy Interest Group, ITMIG)仍然建议选用经Koga等修订的Masaoka分期[1-3]。然而, Masaoka和Koga分期都存在一些模糊的术语定义,尤其是对某些细节未作出明确的定义,造成学术界的许多混乱。为此,ITMIG首先由核心工作组起草推荐定义,再交由扩展工作组提炼,并于2010年11月16日ITMIG举办的定义和术语研讨会上进行了进一步修订,最终经ITMIG全体成员讨论后于2011年2月经ITMIG批准并被采用。其灵魂内容是ITMIG对Masaoka-Koga分期系统的许多细节问题给出了较明确定义与解释,旨在使得大家在应用Masaoka-Koga分期的过程中更加一致,以利于相互合作、资源共享,同时便于前瞻性数据的正确收集,最终提出更合理的分期系统供临床使用。本文就此作一综述。
出处
《中国肺癌杂志》
CAS
北大核心
2014年第2期75-81,共7页
Chinese Journal of Lung Cancer
参考文献18
-
1Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymo-mas with special reference 10 their clinical stages. Cancer, 1981,48: 2485-2492.
-
2Koga K, Matsuno Y, Noguchi M, e t aJ. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int, 1994,44: 359-367.
-
3HuangJ, Wang Z, Loehrer P, et al. Standard outcome measures for thymic malignancies.J Thorac Oncol, 2010, 5: 2017-2023.
-
4Bergh N, Gatzinsky P, Larsson S, et al. Tumors of the thymus and thymic region. L Clinicopathological studies on thymomas. Ann Thorac Surg, 1978, 25: 91-98.
-
5Wilkins EJ, Castleman B. Thymoma: a continuing survey at the Mas?sachusetts General Hospital. Ann Thorac Surg, 1979,28: 252-256.
-
6VerleyJM, Hollmann KH. Thymoma: a comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer, 1985, 55: 1074-1086.
-
7Regnard J-F, Magdeleinat P, Dromer C, et al. Prognostic factors and long?term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg, 1996, 112: 376-384.
-
8WeydertJ, De Young B, Leslie K. Recommendations for the reporting of surgically resected thymic epithelial tumors. AmJ Clin Pathol , 2009, 132: 10-15.
-
9Gamonde's JP, Balawi A, Greenland T, et al. Seventeen years of surgical treatment of thymoma: factors influencing survival. Eur J Cardio-Thorac Surg, 1991,5: 124-131.
-
10Yamakawa Y, Masaoka A, Hashimoto T, et al. A tentative tumor-node?metastasis classification of thymoma. Cancer, 1991,68: 1984-1987.
同被引文献27
-
1Lee JH, Park CM, Park SJ , et al. Value of computerized 3Dshape analysis in differentiating encapsulated from invasive thy-momas[J]. PloS One, 2015,10(5): 1-11.
-
2Nakajima J,Okumura M, Yano M,et al. Myasthenia graviswith thymic epithelial tumour: a retrospective analysis of a Japa-nese database[J], Eur J Cardiothorac Surg, 2016,49(5) : 1510-.
-
3Zhou D, Deng XF, Liu QX,et al. The effectiveness of postop-erative radiotherapy in patients with completely resected thy-moma: A Meta-analysis[J]. Ann Thorac Surg, 2015 , 101 (1):305-310.
-
4Travis W, Brambilla W, Muller- Hermelink H,et al. World healthorganizaion classification of tumors. Pathology and genetics of tumorsof the lung, pleura, thymus and heart [M]. Lyon: I ARC press,2004:145-245.
-
5Moser B, Scharitzer M, Hacker S,et al. Thymomas and thymiccarcinomas: prognostic factors and multimodal management[J].Thorac Cardiovasc Surg, 2014,62(2) : 153-160.
-
6Safieddine N,Liu G,Cuningham K,et al. Prognostic factors forcure, recurrence and long-term survival after surgical resectionof thymomaCJ]. J Thorac Oncol, 2014,9(7) : 1018-1022.
-
7Lindenmann J , Fink-Neuboeck N, Pichler M,et al. Stage-basedtreatment for thymoma in due consideration of thymectomy : asingle-center experience and comparison with the literature[J].World J Surg Oncol,2015, 13(1): 1-7.
-
8Trivino A, Congregado M, Loscertales J,et al. Comparative a-nalysis of video-assisted thoracic surgery versus open resectionfor early-stage thymoma[J]. Cir Esp, 2015,93(7) : 466-471.
-
9Imai H,Kaira K, Yoshino R, et al. Clinical features of patientswith invasive thymoma: A retrospective analysis of 61 cases[j].Surg Pract, 2013, 17(4): 140-148.
-
10李家尧,张卫东,曾敬,王军业.胸腺瘤的CT影像学特征与临床病理相关性分析[J].中华肿瘤防治杂志,2011,18(19):1548-1550. 被引量:9
引证文献5
-
1贾佳,李月敏.术后放疗在胸腺瘤中的作用及研究进展[J].实用医学杂志,2016,32(15):2573-2575. 被引量:4
-
2贾佳,朱慧军,王冰,李月敏.侵袭性胸腺瘤术后三维适形放疗预后分析[J].中华肿瘤防治杂志,2016,23(13):888-892. 被引量:6
-
3秦钢,邢杰,吴佳君,张杰,韩昱晨.弹力纤维染色在评估胸腺瘤对纵隔胸膜侵犯的应用[J].临床与实验病理学杂志,2020,36(1):79-80. 被引量:3
-
4习锦峰,徐全.机器人胸腺扩大切除术在重症肌无力患者中的应用价值[J].中国临床新医学,2023,16(6):542-546. 被引量:3
-
5毛迎港,雷霄,李向柯,杨闽洁,马怡晖,宋丽杰.胸腺神经内分泌肿瘤生存及预后因素分析[J].肿瘤基础与临床,2023,36(4):303-307.
二级引证文献15
-
1岳泓旭,牛中喜.胸腺上皮肿瘤手术治疗进展[J].武警医学,2017,28(3):300-303. 被引量:2
-
2黄玉婷,朱铭,邹文蕙.三维适形放疗与调强放疗在浸润型胸腺瘤术后的效果对比[J].中国当代医药,2017,24(35):15-18.
-
3朱铭,黄玉婷,邹文蕙,赵吉星,李勇生.胸腔镜切除术后组织EGFR和IGF-1R蛋白表达与胸腺瘤患者化疗预后的关系分析[J].中国医药科学,2017,7(24):190-193.
-
4罗红兰,刘凯,姬生威,冯兴勇,刘静.Masaoka Ⅱ期胸腺瘤患者完整手术切除后辅助放疗的疗效及预后分析[J].癌症进展,2018,16(5):606-608. 被引量:1
-
5李磊.CT诊断非侵袭性胸腺瘤和侵袭性胸腺瘤的价值分析[J].山西职工医学院学报,2018,28(4):81-83. 被引量:1
-
6张玉海,李月敏.胸腺瘤三维适形放射治疗与调强放射治疗在共面与非共面照射技术中的剂量学差异[J].广西医学,2019,41(20):2594-2597. 被引量:4
-
7王旭,袁五营,徐文举.局部晚期胸腺切除术中保留膈神经的效果及预后分析[J].医药论坛杂志,2020,41(8):33-37.
-
8陈金平.原发于纵隔706例胸腺瘤的临床病理分析[J].临床与实验病理学杂志,2020,36(11):1338-1340. 被引量:3
-
9王岩,曹玉,殷金环,刘俊峰.胸腺瘤术后患者预后营养指数与总生存率的相关性[J].肿瘤防治研究,2021,48(2):140-144. 被引量:5
-
10刘力华.三维适形放射治疗纵隔转移肿瘤的临床应用优势评价[J].中国现代药物应用,2022,16(15):73-76.
-
1单国际,曾凡华,华瑞,张其刚.61例恶性胸腺瘤患者治疗分析[J].现代肿瘤医学,2008,16(1):50-51. 被引量:3
-
2徐恩五,乔贵宾.胸腺肿瘤分期的历史及进展[J].海南医学,2015,26(20):3029-3033. 被引量:5
-
3付浩,中国胸腺瘤协作组全体成员,James Huang,Frank C.Detterbeck,Zuoheng Wang,Patrick J.Loehrer.胸腺恶性肿瘤预后的标准评估方法[J].中国肺癌杂志,2014,17(2):122-129. 被引量:6
-
4姚云峰.结直肠癌的TNM分期[J].中国医学前沿杂志(电子版),2011,3(6):8-10. 被引量:28
-
5梁寒.胃癌分期的现状与未来[J].消化肿瘤杂志(电子版),2012,4(2):69-70. 被引量:1
-
6尚伟,王琪.2002年头颈肿瘤的TNM分级分期总论[J].国外医学(耳鼻咽喉科学分册),2004,28(1):59-60. 被引量:3
-
7刘荫华,徐玲.第七版《AJCC肿瘤分期手册》结直肠癌内容的更新与解读[J].中华胃肠外科杂志,2010,13(8):629-631. 被引量:52
-
8陈克能.从第八版UICC/AJCC的TNM分期看Ⅳ期肺癌的异质性[J].中华胸部外科电子杂志,2016,3(3):134-137. 被引量:4
-
9薛卫成,顾晋.第7版结直肠癌TNM分期(2010)的变化及意义[J].中华外科杂志,2010,48(21):1605-1606. 被引量:31
-
10姚云峰.结直肠癌的TNM分期[J].中国继续医学教育,2011,3(9):25-27. 被引量:11